Our research into the products, technologies, companies and markets for tissue engineering and cell therapy has revealed that the 2009 market was at $6.9 billion. The market has grown dramatically, in commercialized products and company activity, over the past few years and is on an accelerated growth rate as technology hurdles are overcome and clinical [...]
The number of companies with approved products and measurable revenues in the field of cell therapy and tissue engineering has exceeded the expectation of many (though not all) in the industry.
Markets such as cell/tissue are often characterized by overestimated evaluations of commercial potential and underestimated consideration of the actual challenges. Indeed many technology challenges remain [...]
Since the fundamental problem in Type 1 diabetes (or juvenile onset, diabetes mellitus) is that the islets cells in the pancreas no longer produce insulin (as opposed to Type 2 diabetes, in which the insulin produced is inadequate in form or amount), the solution to Type 1 is "simply" to replace this function. For all [...]
Tissue engineering involves taking either autologous, allogeneic or xenogeneic cells and redirecting those cells to carry out fundamental processes. Often the researcher will use a biomaterial matrix and seed the cells into this matrix. The redirection may take the form of stimulating the cells to become stem cells or precursor cells, or it may mean [...]
In treatment of acute and chronic wounds, the advanced wound technologies developed by manufacturers provide benefits that facilitate healing, minimize infection and provide other benefits toward reduced cost, less pain, faster healing and combinations of these and other benefits. Advanced products in wound care include film dressings, hydrocolloids, foam dressings, alginate dressings, hydrogels, non-adherent dressings, [...]
Wound management encompasses a wide range of products: fabric dressings, first aid dressings, dressings and internal wound management products for surgery, advanced wound management products, active pharmaceutical wound care products, tissue engineering, physical therapies for wound care, and pressure relief products and skin treatments, for preventative wound management.
MedMarket Diligence is finalizing its analysis (publication September [...]
Discussed in a press release from the University of Virginia Health System, "Aritificial Pancreas Proves Effective in Treating Type 1 Diabetes Overnight in Pilot Study."
Researchers at the University of Virginia Health System are reporting remarkable results from their pilot clinical study of the artificial pancreas, a computerized, subcutaneous system that could one day revolutionize the way [...]
Obesity puts a burden on so many aspects of life that the socioeconomic cost is almost inevitably enormous—as well as challenging to quantify. At the individual level, there is the lower quality of life, days missed from work, decreased wages, premature retirement, potentially unemployment, and the medical costs of related illnesses, which may include depression, [...]
Specific technologies and broad technology platforms have tremendous potential for market growth based on combinations of recent technology advancement, changes in clinical practice, current forces in the market and other criterial.
Biotech solutions to traditional medical device technologies. The thrust of medical technology is, and has been for a long time, to make it as effective as [...]
Diabetes represents one classic "co-morbitiy" with obesity, but also one that is frequently cited for its impact on healthcare and, by extension, healthcare costs.
Co-Morbidities Linked to Obesity
When we eat, we either take in glucose directly or the body converts complex carbohydrates to glucose. However, the body’s cells can’t take in and utilize glucose to make [...]
Contact:
